Intervention

sitaxentan

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 2 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials2

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

2 shown

A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple DosesNCT01244620 · 2010-11-01

TERMINATED

Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe AsthmaNCT01050491 · 2009-11-01

TERMINATED

Common conditions

Effect of Sitaxsentan on Airway Remodeling in Severe Asthma1 Pulmonary Arterial Hypertension1

Leading sponsors

Institut National de la Santé Et de la Recherche Médicale, France 1 Pfizer 1

Trial status mix

TERMINATED2

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.